We observed that CD4+ PD-1+ GITs were accumulated in the regions surrounding gp96+ glioma cells, whereas CD4+ PD-1− GITs were relatively evenly distributed across the tumor tissues. This evidence concerns the gene CD4 and central nervous system cancer.